Mediators of the effect of exercise-based cardiac rehabilitation on hospitalisation risk in people with coronary heart disease – the CaReMATCH individual participant data meta-analysis
Discover how exercise-based cardiac rehabilitation improves physical and mental quality of life to reduce hospitalisation risk in people with coronary heart disease.
Exercise-based cardiac rehabilitation for coronary heart disease: the CaReMATCH individual participant data meta-analysis
Explore how exercise-based cardiac rehabilitation reduces hospitalisation risk and improves quality of life for people with coronary heart disease.
Exercise-based cardiac rehabilitation for patients with angina pectoris - a CaReMATCH individual participant data meta-analysis
Exercise-based cardiac rehabilitation affects health-related quality of life in patients with angina pectoris. This is based on the CaReMATCH meta-analysis.
Life's essential 8 score and 10-year cardiovascular outcomes in atrial fibrillation: A UK biobank analysis with simulated lifestyle improvement
The American Heart Association’s Life’s Essential 8 score relates to 10-year cardiovascular outcomes and mortality risk in people with atrial fibrillation.
Impact of patient phenotype on the relationship between accelerometer-derived physical activity and cardiovascular events in atrial fibrillation
Physical activity levels relate to cardiovascular event risk across different atrial fibrillation phenotypes. This research uses accelerometer data from the UK Biobank.
Exercise based cardiac rehabilitation for atrial fibrillation: Cochrane systematic review, meta-analysis, meta-regression and trial sequential analysis
The evidence on exercise-based cardiac rehabilitation for atrial fibrillation is based on a Cochrane systematic review, meta-analysis and trial sequential analysis.
Exercise-based cardiac rehabilitation for patients with atrial fibrillation: a narrative review
Understand the evidence for exercise-based cardiac rehabilitation in atrial fibrillation, including its effects on AF burden, cardiovascular risk, quality of life and barriers to uptake.
Cardiac Biomarkers Predict Major Adverse Cardiac Events (MACE) in Incident Haemodialysis Patients: Results from a Global Federated Database
Discover how elevated troponin I and BNP levels predict major adverse cardiac events in patients starting haemodialysis, highlighting opportunities for improved cardiovascular risk assessment.
Exercise-based cardiac rehabilitation for patients with atrial fibrillation receiving catheter ablation: protocol for a feasibility randomised controlled trial (RCT) with embedded process evaluation
Exercise-based cardiac rehabilitation for adults with atrial fibrillation
Routine cardiac biomarkers for the prediction of incident major adverse cardiac events in patients with glomerulonephritis: a real-world analysis using a global federated database
Cardiac rehabilitation and adverse events among adult patients with simple congenital heart disease and heart failure
Comprehensive ‘Cardiovascular Health’ Rehabilitation: An integrated approach to improve prevention and rehabilitation of cardiovascular diseases
Oral anticoagulants and outcomes in adults ≥80 years with atrial fibrillation: A global federated health network analysis
Effectiveness and safety of apixaban in >3.9 million people with atrial fibrillation: A systematic review and meta-analysis
Exercise-based cardiac rehabilitation associates with lower major adverse cardiovascular events in people with stroke. Cerebrovascular Diseases
Exercise-based cardiac rehabilitation vs. percutaneous coronary intervention for chronic coronary syndrome: impact on morbidity and mortality
Exercise-based cardiac rehabilitation with all-cause mortality among patients with atrial fibrillation
Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients
Exercise-based cardiac rehabilitation for cardiac implantable electronic device recipients
Cardiac rehabilitation and all-cause mortality in patients with heart failure
Association of Exercise-Based Cardiac Rehabilitation with Progression of Paroxysmal to Sustained Atrial Fibrillation
Stroke-heart syndrome and risk of incident dementia among patients with first-ever ischemic stroke: A territory-wide population-based cohort study
Stroke-heart syndrome is associated with dementia risk after an ischaemic stroke. See how appropriate treatment and management of other health conditions may help reduce cognitive risks.
Integrated care management for patients following acute stroke: a systematic review
Explore how integrated care after acute stroke affects patient outcomes, including recurrent stroke, quality of life and depression, and which care strategies may offer the greatest benefits.
Left Atrial Appendage Occlusion versus Direct Oral Anticoagulants in the Prevention of Ischaemic Stroke in Patients with Atrial Fibrillation
Compare left atrial appendage occlusion with direct oral anticoagulants for preventing ischaemic stroke in patients with atrial fibrillation, examining five-year outcomes for stroke, mortality and intracranial bleeding.
Incident dementia in ischaemic stroke patients with early cardiac complications: A propensity-score matched cohort study
The association between early cardiac complications after ischaemic stroke and the risk of developing dementia includes the increased risk during the first month and the role of vascular and mixed dementia.
Stroke-heart syndrome: Incidence and clinical outcomes of cardiac complications following intracerebral haemorrhage
Explore the incidence of stroke-heart syndrome after intracerebral haemorrhage and its association with five-year cardiovascular outcomes, including heart attack, ischaemic stroke, death and recurrent brain haemorrhage.
Direct oral anticoagulants are associated with lower risk of dementia in patients with atrial fibrillation
Understand how direct oral anticoagulants (DOACs) compare with vitamin K antagonists (VKAs) in their association with long-term risks of all-cause dementia and vascular dementia in people with atrial fibrillation.
Catheter ablation and lower risk of incident dementia and mortality in older adults with atrial fibrillation
Find the association between catheter ablation and the risk of dementia and mortality in adults aged 65 and over with atrial fibrillation, including differences across patient subgroups.
Stroke–heart syndrome: mechanisms, risk factors, and adverse cardiovascular events
There are mechanisms and risk factors associated with stroke–heart syndrome, including sex-specific differences in incidence and five-year risks of mortality, recurrent stroke and heart attack.
Risk of myocardial infarction and ischemic stroke in individuals with first-diagnosed paroxysmal vs. non-paroxysmal atrial fibrillation under anticoagulation
Compare three-year risks of heart attack and ischaemic stroke in people with newly diagnosed paroxysmal versus persistent or chronic atrial fibrillation receiving anticoagulant treatment.
C-reactive protein levels are associated with early cardiac complications or death in patients with acute ischemic stroke: a propensity-matched analysis of a global federated health from the TriNetX network
See how C-reactive protein (CRP) levels measured within 24 hours of an ischaemic stroke are associated with the risk of cardiac complications and death during the following 30 days.
Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis
Alzheimer’s disease and vascular dementia are associated with four-year risks of intracranial bleeding, ischaemic stroke, transient ischaemic attack, hospitalisation and death in people with atrial fibrillation.
Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke
Combining oral anticoagulants with antiplatelet agents is associated with one-year risks of recurrent stroke, major bleeding and death in patients with atrial fibrillation and carotid artery disease after a first ischaemic stroke.
Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis
Discover how co-existing thoracic aortic aneurysm and atrial fibrillation are associated with a higher risk of ischaemic stroke, transient ischaemic attack and major bleeding over three years.
Evaluation of Huawei Smart Wearables for Detection of Atrial Fibrillation in Patients Following Ischaemic Stroke: The Liverpool-Huawei Stroke Study
Huawei smart wearables are being evaluated for detecting atrial fibrillation after ischaemic stroke, including their accuracy, cost-effectiveness and acceptability to patients and healthcare staff.
The Liverpool Heart And bRain Project (L-HARP): Protocol for an Observational Cohort Study of Cardiovascular Risk and Outcomes Following Stroke
The Liverpool Heart and bRain Project (L-HARP) aims to improve understanding of cardiovascular risks, recurrent stroke, atrial fibrillation and cognitive outcomes following stroke or transient ischaemic attack.
Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke
See how newly diagnosed cardiac complications within four weeks of an ischaemic stroke are associated with five-year risks of death, recurrent stroke, hospitalisation and heart attack.
Comparative impact of mental and cardiovascular comorbidities on adverse outcomes in people with MS
Explore how mental health and cardiovascular conditions are associated with disease progression and quality of life in people with multiple sclerosis (MS), highlighting the importance of integrated care.
Vitamin D and cardiovascular outcomes in multiple sclerosis
Understand the association between vitamin D levels and long-term cardiovascular outcomes in people with multiple sclerosis (MS), including whether vitamin D supplementation is linked to cardiovascular risk.
